Chinese Said Eyeing Braskem Takeover

China could be poised for another spectacular takeover of a Western company, as China National Offshore Oil Corporation (CNOOC) is seen to be mulling a deal for Brazilian petrochemicals giant Braskem.

According to Brazilian news reports, CNOOC is already in talks with one of the company’s two major shareholders, state-owned oil company Petrobras with 36%, and the news agency Reuters said it may also be aiming to buy the 38% held by the largest shareholder construction conglomerate Odebrecht.

Earlier Reuters reports pointed to interest by Canadian private equity group Brookfield and Saudi Aramco.

Both potential sellers are said to need cash to finance ambitious expansion plans, and Odebrecht is believed to be under pressure to repay $130 billion in outstanding debts. At the same time, the company is embroiled in a corruption scandal, also thought to involve Petrobras, which has reportedly blocked its access to capital.

A sale by both shareholders would leave nearly 75% of Braskem in Chinese hands. Companies from the People’s Republic are already in the spotlight due to several recent major deals, including the planned acquisition of Swiss agrochemicals giant Syngenta for $43 billion and the purchase of German plastics machinery producer KraussMaffei for $1.1 billion at the beginning of this year.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.